INFLAMASE FORTE Rx
Generic Name and Formulations:
Prednisolone sodium phosphate 1%; oph soln; contains benzalkonium chloride.
Indications for INFLAMASE FORTE:
Initially 1–2 drops every hour during day and every 2 hours at night; after response, reduce to 1 drop every 4 hours; then 1 drop 3–4 times daily as needed.
Ocular fungal, mycobacterial, viral (except herpes zoster), or untreated bacterial infections.
Not for use after uncomplicated removal of foreign body. Corneal or scleral thinning. Glaucoma. Monitor IOP and for secondary infections. Avoid abrupt cessation in prolonged use. Pregnancy (Cat.C). Nursing mothers.
Prolonged use: increased IOP, cataracts, corneal perforations, optic nerve damage, delayed wound healing; may mask or worsen infections.
Soln—5mL, 10mL, 15mL
Endocrinology Advisor Articles
- Insulin Analogs vs Regular Human Insulin for Type 2 Diabetes
- Trends in Bisphosphonate Use and Hip Fracture Rates in Denmark
- Gender-Affirming Hormonal Treatment and Long-Term Bone Safety
- Primary Characteristics of PCOS Predictive of Obstetric Complications
- Maternal Thyroid Function in Pregnancy Linked to Childhood Risk for Disease
- Sleep Habits Affect Insulin Sensitivity in Adolescents With Overweight, Obesity
- Levothyroxine Associated With Increased Mortality in Patients With Heart Failure
- Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
- Dual vs Triple Therapy for Metformin Treatment Intensification in Type 2 Diabetes
- Familial Hypercholesterolemia: An Underdiagnosed Disease Gets a Second Look
- FDA Committee Votes on Oral T1D Treatment Sotagliflozin
- Elevated Plasma Agouti-Related Protein May Be a Marker for Cushing Disease
- Therapeutic Effect of Long-Chain PUFA Omega 3 Supplementation in Obese Children
- Poor Health Outcomes Associated With Fear of Crime, Violence Among College Students of Color
- Safety of PCSK9 Inhibitors After Heart Transplantation Examined